The Feasibility of Omission of Postoperative Radiotherapy in Japanese Patients With Early Breast Cancer Treated With Breast-Conserving Surgery

被引:0
|
作者
Nakashima, Akihiro [1 ]
Yamazaki, Hideya [1 ]
Suzuki, Gen [2 ]
Yamada, Kei [1 ]
Aibe, Norihiro [1 ]
Kimoto, Takuya [1 ]
Masui, Koji [1 ]
Nakatsukasa, Katsuhiko [3 ]
Taguchi, Tetsuya [3 ]
Naoi, Yasuto [3 ]
机构
[1] Kyoto Prefectural Univ Med, Radiol, Kyoto, Japan
[2] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Radiol, Kyoto, Japan
[3] Kyoto Prefectural Univ Med, Endocrine & Breast Surg, Kyoto, Japan
关键词
breast-conserving surgery; invasive carcinoma; omission of postoperative radiotherapy; postoperative radiotherapy; breast cancer; LUMPECTOMY PLUS TAMOXIFEN; IRRADIATION; WOMEN; OLDER; SURVIVAL; THERAPY; AGE;
D O I
10.7759/cureus.60228
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background This study was aimed at analyzing the impact of postoperative radiotherapy (PORT) after breast-conserving surgery (BCS) on Japanese patients with early-stage breast cancer and exploring the potential of PORT omission. Materials and methods Data from 794 patients with early-stage breast cancer (T1-2, N0-1), who underwent BCS with (n = 310) or without PORT (n = 484) were retrospectively analyzed. Local control (LC) rate and breast cancer-specific survival (BCSS) were compared between the groups that received and did not receive PORT in the whole cohort and low-risk cohort (i.e., the cohort with negative surgical margin, lymph node negativity, and estrogen receptor positivity, excluding young age of 49 or less), and in low-risk subgroup using propensityscore matching. Results PORT was associated with better LC but not BCSS in the total population. In the low-risk cohort, the incidence of local recurrence in patients without and with PORT was 5.3% and 4.8%, respectively, at 10 years (p = 0.591), and 7.8% and 4.8%, respectively, according to propensity-score matching (p = 0.485). Conclusion PORT improved LC in the total population, but not BCSS or overall survival (OS). In the low-risk group analysis (negative surgical margin, lymph node negativity, estrogen receptor positivity, and age 50 years or more), equivalent LC, BCSS, and OS were found including propensity-matched comparison. Therefore, this study showed that the omission of PORT could be a treatment option for low-risk Japanese patients. Further multi -center prospective studies are warranted to validate these findings and reduce the unnecessary burden of PORT for patients and institutions.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Breast-Conserving Surgery in Breast Cancer
    Cojan, T. S. Tenea
    Vidrighin, C. D.
    Ciobanu, M.
    Paun, I.
    Teodorescu, M.
    Mogos, G.
    Tenovici, M.
    Florescu, M.
    Mogos, D.
    CHIRURGIA, 2012, 107 (05) : 616 - 625
  • [32] Breast-conserving surgery for breast cancer
    Apantaku, LM
    AMERICAN FAMILY PHYSICIAN, 2002, 66 (12) : 2271 - 2278
  • [33] Omission of radiotherapy after breast-conserving surgery: survival impact and time trends
    Vinh-Hung, V
    Voordeckers, M
    Van de Steene, J
    Soete, G
    Lamote, J
    Storme, G
    RADIOTHERAPY AND ONCOLOGY, 2003, 67 (02) : 147 - 158
  • [34] Breast conserving surgery and radiotherapy for early breast cancer
    Cheng, SH
    Chen, CM
    Jian, JJ
    Tsai, SY
    Liu, TW
    Liu, MC
    Chen, CMC
    Lin, HH
    JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 1996, 95 (05) : 372 - 377
  • [35] Breast-conserving surgery in breast cancer
    Ruggiero, R.
    Procaccini, E.
    Freda, F.
    Iovino, F.
    Irlandese, E.
    Gili, S.
    Lo Schiavo, F.
    GIORNALE DI CHIRURGIA, 2005, 26 (11-12): : 449 - 452
  • [36] Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients
    Reitsamer, R
    Peintinger, F
    Sedlmayer, F
    Kopp, M
    Menzel, C
    Cimpoca, W
    Glueck, S
    Rahim, H
    Kopp, P
    Deutschmann, H
    Merz, F
    Brandis, M
    Kogelnik, H
    EUROPEAN JOURNAL OF CANCER, 2002, 38 (12) : 1607 - 1610
  • [37] Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery
    Garvin, Stina
    Oda, Husam
    Arnesson, Lars-Gunnar
    Lindstrom, Annelie
    Shabo, Ivan
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2018, 144 (07) : 1253 - 1263
  • [38] Tumor cell expression of CD163 is associated to postoperative radiotherapy and poor prognosis in patients with breast cancer treated with breast-conserving surgery
    Stina Garvin
    Husam Oda
    Lars-Gunnar Arnesson
    Annelie Lindström
    Ivan Shabo
    Journal of Cancer Research and Clinical Oncology, 2018, 144 : 1253 - 1263
  • [39] Omitting Radiotherapy after Breast-Conserving Surgery in Luminal A Breast Cancer
    Whelan, Timothy J.
    Smith, Sally
    Parpia, Sameer
    Fyles, Anthony W.
    Bane, Anita
    Liu, Fei-Fei
    Rakovitch, Eileen
    Chang, Lynn
    Stevens, Christiaan
    Bowen, Julie
    Provencher, Sawyna
    Theberge, Valerie
    Mulligan, Anna Marie
    Kos, Zuzana
    Akra, Mohamed A.
    Voduc, K. David
    Hijal, Tarek
    Dayes, Ian S.
    Pond, Gregory
    Wright, James R.
    Nielsen, Torsten O.
    Levine, Mark N.
    NEW ENGLAND JOURNAL OF MEDICINE, 2023, 389 (07): : 612 - 619
  • [40] Sequence of Radiotherapy and Chemotherapy in Breast Cancer After Breast-Conserving Surgery
    Jobsen, Jan J.
    Van der Palen, Job
    Brinkhuis, Mariel
    Ong, Francisca
    Struikmans, Henk
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2012, 82 (05): : E811 - E817